picotamide has been researched along with Diseases, Peripheral Vascular in 7 studies
picotamide: has anticoagulant & fibrinolytic properties; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "Picotamide treatment caused a decrease of resting thromboxane B2 and endothelin-1 concentrations, produced an improvement of the vascular function as seen by the increase of vascular parameters reported, and attenuated the ischemic treadmill-induced increase of thromboxane B2, but not of endothelin-1." | 1.30 | Effects of picotamide on release of endothelin-1, thromboxane and prostacycline after treadmill stress in patients with peripheral artery disease. ( Bonaiuto, M; Campo, GM; Castaldo, M; Cinquegrani, M; D'Arrigo, D; Giordano, G; Imbalzano, E; Saitta, A; Sardo, A; Squadrito, F, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gresele, P | 1 |
| Migliacci, R | 1 |
| Neri Serneri, GG | 1 |
| Coccheri, S | 1 |
| Marubini, E | 1 |
| Violi, F | 2 |
| Hiatt, WR | 1 |
| Krantz, MJ | 1 |
| Hackam, DG | 1 |
| Neirotti, M | 1 |
| Molaschi, M | 1 |
| Ponzetto, M | 1 |
| Macchione, C | 1 |
| Poli, L | 1 |
| Bonino, F | 1 |
| Fabris, F | 1 |
| Criqui, M | 1 |
| Longoni, A | 1 |
| Castiglioni, C | 1 |
| Saitta, A | 1 |
| Sardo, A | 1 |
| Bonaiuto, M | 1 |
| Giordano, G | 1 |
| Imbalzano, E | 1 |
| Castaldo, M | 1 |
| Cinquegrani, M | 1 |
| D'Arrigo, D | 1 |
| Campo, GM | 1 |
| Squadrito, F | 1 |
1 review available for picotamide and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
Masterclass series in peripheral arterial disease. Antiplatelet therapy for peripheral arterial disease and claudication.
Topics: Aspirin; Atherosclerosis; Clopidogrel; Drug Therapy, Combination; Humans; Intermittent Claudication; | 2006 |
3 trials available for picotamide and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
Topics: Adult; Aged; Aspirin; Diabetic Angiopathies; Double-Blind Method; Female; Follow-Up Studies; Humans; | 2004 |
Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
Topics: Arterial Occlusive Diseases; beta-Thromboglobulin; Blood Coagulation; Blood Viscosity; Double-Blind | 1994 |
Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study.
Topics: Adult; Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Comorbidity; Diabetes Mellitus; Dis | 1996 |
3 other studies available for picotamide and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
Picotamide versus aspirin in diabetic patients with peripheral arterial disease: has David defeated Goliath?
Topics: Arteries; Aspirin; Diabetic Angiopathies; Humans; Peripheral Vascular Diseases; Phthalic Acids; Plat | 2004 |
Medical management of peripheral arterial disease.
Topics: Aspirin; Clopidogrel; Cost-Benefit Analysis; Humans; Peripheral Vascular Diseases; Phthalic Acids; P | 2006 |
Effects of picotamide on release of endothelin-1, thromboxane and prostacycline after treadmill stress in patients with peripheral artery disease.
Topics: Aged; Endothelin-1; Exercise Test; Female; Humans; Male; Middle Aged; Peripheral Vascular Diseases; | 1998 |